TCR-specific, alpha fetoprotein-enhanced autologous T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-017002
A preparation of human autologous T lymphocytes transduced with a viral vector encoding for a T-cell receptor (TCR) specific for human alpha-fetoprotein (AFP), with potential antineoplastic activity. Following administration, the TCR-specific, alpha fetoprotein-enhanced autologous T lymphocytes recognize and bind to AFP antigen-positive cells, which results in lysis and killing of AFP-positive cancer cells. AFP is overexpressed in a variety of cancers.
| Identifier | MLC-T-ONC-017002 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | AFP-C332 T cells |
| Synonyms | AFP-C332 CTLs; anti-AFP TCR-expressing autologous CTLs |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017002",
"term": "TCR-specific, alpha fetoprotein-enhanced autologous T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of human autologous T lymphocytes transduced with a viral vector encoding for a T-cell receptor (TCR) specific for human alpha-fetoprotein (AFP), with potential antineoplastic activity. Following administration, the TCR-specific, alpha fetoprotein-enhanced autologous T lymphocytes recognize and bind to AFP antigen-positive cells, which results in lysis and killing of AFP-positive cancer cells. AFP is overexpressed in a variety of cancers.",
"abbreviation": "AFP-C332 T cells",
"synonyms": [
"AFP-C332 CTLs",
"anti-AFP TCR-expressing autologous CTLs"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tcr-specific-alpha-fetoprotein-enhanced-autologous-t-lymphocytes/"
}
Record 16,051 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.